Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Company research

Health Assurance Acquisition Corp.

CIK 1824013Updated Sep 26, 2026

Name history
Healthcare Assurance Acquisition Corp. · through Sep 28, 2020

HAAC price & chart

Provider market data
Historical security

This listing closed Nov 3, 2022. Live provider charts are shown only for current listings.

In the news

No coverage from other publishers is available.

Recent filings

  1. 15-12G filing

    15-12G · 2022-11-14 · 0001104659-22-118582

  2. 25-NSE filing

    25-NSE · 2022-11-03 · 0001354457-22-000633

  3. 8-K filing

    8-K · 2022-10-27 · 0001104659-22-112039

  4. UPLOAD filing

    UPLOAD · 2022-08-25 · 0000000000-22-009207

  5. CORRESP filing

    CORRESP · 2022-08-23 · 0001104659-22-093723

Show 5 more recent filings
  1. 10-K/A filing

    10-K/A · 2022-08-23 · 0001104659-22-093718

  2. UPLOAD filing

    UPLOAD · 2022-08-12 · 0000000000-22-008604

  3. 10-Q filing

    10-Q · 2022-08-12 · 0001104659-22-089556

  4. 10-Q filing

    10-Q · 2022-05-16 · 0001104659-22-060959

  5. 8-K filing

    8-K · 2022-04-05 · 0001104659-22-042784

Financials

FY 2021 · USD
Revenue— · FY 2021
Net income46,607,984USD · FY 2021
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

Operating income-6,516,853USD · FY 2021
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

Diluted EPS— · FY 2021

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2021FY 2020
ASSETS
AssetsUSD526,974,148
Source

10-K · 2022-03-30 · 0001104659-22-039660

As of 2021-12-31

532,168,717
Source

10-K/A · 2022-01-06 · 0001104659-22-001959

As of 2020-11-17

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD1,084,776
Source

10-K · 2022-03-30 · 0001104659-22-039660

As of 2021-12-31

—
Assets, CurrentUSD1,729,979
Source

10-K · 2022-03-30 · 0001104659-22-039660

As of 2021-12-31

—
LIABILITIES AND EQUITY
LiabilitiesUSD44,660,091
Source

10-K · 2022-03-30 · 0001104659-22-039660

As of 2021-12-31

81,098,126
Source

10-K/A · 2022-01-06 · 0001104659-22-001959

As of 2020-11-17

Stockholders’ equity:
Retained Earnings (Accumulated Deficit)USD-42,686,206
Source

10-K · 2022-03-30 · 0001104659-22-039660

As of 2021-12-31

-73,929,697
Source

10-K/A · 2022-01-06 · 0001104659-22-001959

As of 2020-11-17

Stockholders' Equity Attributable to ParentUSD-42,685,943
Source

10-K · 2022-03-30 · 0001104659-22-039660

As of 2021-12-31

-73,929,409
Source

10-K/A · 2022-01-06 · 0001104659-22-001959

As of 2020-11-17

Liabilities and EquityUSD526,974,148
Source

10-K · 2022-03-30 · 0001104659-22-039660

As of 2021-12-31

532,168,717
Source

10-K/A · 2022-01-06 · 0001104659-22-001959

As of 2020-11-17

Current liabilities:
Liabilities, CurrentUSD2,848,092
Source

10-K · 2022-03-30 · 0001104659-22-039660

As of 2021-12-31

—
Accounts Payable, CurrentUSD63,817
Source

10-K · 2022-03-30 · 0001104659-22-039660

As of 2021-12-31

—
Additional Financial Items
Accrued Liabilities, CurrentUSD2,617,283
Source

10-K · 2022-03-30 · 0001104659-22-039660

As of 2021-12-31

—

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2021FY 2020
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD46,607,984
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

—
Adjustments to reconcile net income to net cash provided by operating activities:
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts PayableUSD38,990
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

—
Net Cash Provided by (Used in) Operating ActivitiesUSD-3,530,318
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

—
Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD1,084,776
Source

10-K · 2022-03-30 · 0001104659-22-039660

As of 2021-12-31

4,615,094
Source

10-K · 2021-03-04 · 0001104659-21-032185

As of 2020-12-31

Additional Financial Items
Gain (Loss) on InvestmentsUSD178,638
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

—
General and Administrative ExpenseUSD5,286,802
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

—
Income Tax Expense (Benefit)USD5,881
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

—
Net Income (Loss) Attributable to ParentUSD46,607,984
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

—
Unrealized Gain (Loss) on InvestmentsUSD178,638
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

—

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2021
Operating Income (Loss)USD-6,516,853
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD46,613,865
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

Income Tax Expense (Benefit)USD5,881
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

Net Income (Loss) Attributable to ParentUSD46,607,984
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

Additional Financial Items
Gain (Loss) on InvestmentsUSD178,638
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

General and Administrative ExpenseUSD5,286,802
Source

10-K · 2022-03-30 · 0001104659-22-039660

2021-01-01 to 2021-12-31

Lines labelled “Derived” are calculated from reported figures.